Sale!

Lung Cancer Panel 2 EGFRALK1ROS1 Test

Original price was: 6,000 د.إ.Current price is: 4,500 د.إ.

-25%

The Lung Cancer Panel 2 EGFR/ALK1/ROS1 Test offered by DNA Labs UAE is a comprehensive diagnostic tool designed to identify specific genetic mutations associated with lung cancer. Priced at 4500 AED, this test focuses on the detection of mutations in the EGFR, ALK1, and ROS1 genes, which are critical in the development and progression of lung cancer. By pinpointing these mutations, the test aids in determining the most effective treatment plan for patients, enabling personalized therapy approaches. This advanced molecular testing is crucial for patients with non-small cell lung cancer (NSCLC), as targeted therapies can significantly improve outcomes for those with identifiable mutations. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test ensures high accuracy and reliability, providing essential insights for oncologists and patients navigating lung cancer treatment options.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Lung Cancer Panel 2 EGFRALK1ROS1 Test

Test Name: Lung Cancer Panel 2 EGFRALK1ROS1 Test

Components: Paraffin embedded tissue blocks

Price: 4500.0 AED

Sample Condition: Tumor tissue

Report Delivery: 5-7 days

Method: FISH, Sanger Sequencing

Test type: Genetics

Doctor: Oncology

Test Department: DNA Labs UAE

Pre Test Information: Lung Cancer Panel 2 EGFRALK1ROS1 Test can be done with a Doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details

The Lung Cancer Panel 2 includes testing for three specific genetic mutations that are commonly found in lung cancer patients: EGFR, ALK1, and ROS1.

EGFR (epidermal growth factor receptor): EGFR is a protein that is involved in cell growth and division. Mutations in the EGFR gene can cause cells to grow and divide uncontrollably, leading to the development of cancer. EGFR mutations are found in about 10-15% of lung cancer cases, and patients with these mutations may respond well to targeted therapies such as EGFR inhibitors.

ALK1 (anaplastic lymphoma kinase): ALK1 is another protein that is involved in cell growth and division. ALK1 mutations can also lead to uncontrolled cell growth and the development of cancer. ALK1 mutations are found in about 5% of lung cancer cases, and patients with these mutations may respond well to targeted therapies such as ALK inhibitors.

ROS1 (c-ros oncogene 1): ROS1 is a gene that produces a protein involved in cell signaling. ROS1 mutations can also lead to the development of cancer. ROS1 mutations are found in about 1-2% of lung cancer cases, and patients with these mutations may respond well to targeted therapies such as ROS1 inhibitors.

Testing for these mutations can help guide treatment decisions for lung cancer patients and improve their chances of a successful outcome.

Test Name Lung Cancer Panel 2 EGFRALK1ROS1 Test
Components Paraffin embedded tissue blocks
Price 4500.0 AED
Sample Condition Tumor tissue
Report Delivery 5-7 days
Method FISH,Sanger Sequencing
Test type Genetics
Doctor Oncology
Test Department:
Pre Test Information Lung Cancer Panel 2 EGFR,ALK1,ROS1] can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

The Lung Cancer Panel 2 includes testing for three specific genetic mutations that are commonly found in lung cancer patients: EGFR, ALK1, and ROS1.

EGFR (epidermal growth factor receptor) is a protein that is involved in cell growth and division. Mutations in the EGFR gene can cause cells to grow and divide uncontrollably, leading to the development of cancer. EGFR mutations are found in about 10-15% of lung cancer cases, and patients with these mutations may respond well to targeted therapies such as EGFR inhibitors.

ALK1 (anaplastic lymphoma kinase) is another protein that is involved in cell growth and division. ALK1 mutations can also lead to uncontrolled cell growth and the development of cancer. ALK1 mutations are found in about 5% of lung cancer cases, and patients with these mutations may respond well to targeted therapies such as ALK inhibitors.

ROS1 (c-ros oncogene 1) is a gene that produces a protein involved in cell signaling. ROS1 mutations can also lead to the development of cancer. ROS1 mutations are found in about 1-2% of lung cancer cases, and patients with these mutations may respond well to targeted therapies such as ROS1 inhibitors.

Testing for these mutations can help guide treatment decisions for lung cancer patients and improve their chances of a successful outcome.